Read our latest blog on the many benefits to achieving organic certification
This column examines the role and mechanisms of cell culture techniques including its strong points and limitations for testing cannabis products
On this episode, we are joined by Dr. Iain Oswald, a principal research scientist at Abstrax Tech Inc.
April 30, 2024
Multiple sources have reported that the US Drug Enforcement Administration will move to reclassify marijuana from Schedule I to Schedule III, effectively recognizing medical uses of cannabis and its reduced potential for abuse compared with other drugs.
Here, Darwin Millard, Technical Director of CSQ, discusses the present and potential future of cannabis standards and regulations.
April 27, 2024
In this interview, Darwin Millard shares what attendees will experience in the two ASTM Subcommittee meetings he will be guiding.
April 25, 2024
In this interview, Jimmy Farrell, Standards Development Manager at ASTM International, explains the important role ASTM plays in safety and quality of the global cannabis industry.
In this interview, Jimmy Farrell explains more on this opportunity to shape standards and methods in the global cannabis industry.
In the second installment in this webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon discuss implementation of cannabis as a harm reduction agent from a clinical perspective.
April 24, 2024
Our sister publication, LCGC International, sat down with Zacariah Hildenbrand, PhD, Chief Science Officer of Infinity Water Solutions and Partner of Medusa Analytical, for more insight into various trends in cannabis testing.
April 23, 2024
Kentucky Governor signs HB 829, and introduces lottery for dispensary applications.
April 22, 2024
Trilogene Seeds recently announced the release of their new triploid THCa cannabis seeds.
April 20, 2024
In recognizing the 4/20 holiday, here is a selection of regulatory updates and commentary in the cannabis industry this year so far.